We have studied the induction of the cytotoxic T lymphocyte (CTL) response to measles virus (MV) antigens expressed as vaccinia virus (VV) recombinants in a murine model. In C3H mice (H-2 k) only the nucleoprotein (NP) induced a CTL response and this was shown to be cross-reactive with the closely related canine distemper virus (CDV). The presentation of this antigen was shown to be Kk-restricted. In BALB/c mice (H-2d), both the haemagglutinin (HA) and the NP induced a strong CTL response, the former being serotype-specific, whereas the latter cross-reacted with CDV. Both responses were found to be La-restricted. Based on the prediction for L d T cell motifs, we tested a number of MV NP-derived nonapeptides for their capacity to sensitize P815 cells (H-2 o) for lysis by spleen cells from VV-NP-immunized mice. One of these peptides, comprising amino acids 281 to 289 (Tyr-ProAla-Leu-Gly-Leu-His-Glu-Phe) was as effective as cells expressing the complete NP protein. This motif is conserved in the CDV NP.
Introduction
Measles virus (MV) is responsible for an acute respiratory tract infection that is a major cause of infant mortality in the Third World. The present vaccine has had little effect in preventing the annual epidemics observed in these countries. This is due in part to the early age at which the children become infected and the inability to vaccinate efficiently in the presence of maternal antibody. Epidemics have also occurred recently in industrialized countries. In the U.S.A. for example, college-age students have succumbed to acute measles infection despite a 30-year vaccination programme which hitherto had been highly successful in combating the disease. Waning immunity and inefficient vaccine coverage are among a number of hypotheses that can be put forward to account for this situation, but the actual causes remain to be elucidated.
Successful immunization against a viral infection depends on a number of factors. Natural infections induce both humoral and cell-mediated immunity (CMI) involving both T helper and cytotoxic T lymphocyte (CTL) populations. For certain viruses, protection is correlated directly with the induction of neutralizing antibody. Furthermore, passive administration of hyperimmune serum can prevent infection. However, for certain other viruses such as lymphocytic choriomeningitis virus, protection is provided mainly by CTLs of the CD8 + phenotype (Klavinskis et al., 1990) . To propose new vaccine strategies, it is important to analyse the contribution of the different immune responses and study their effect on viral infection. A potential vaccine can then be reconstituted using the defined parameters.
In our previous studies, we have used vaccinia virus (VV) as a vector for MV antigens to establish the contribution of the individual viral antigens in protection against MV infection. In a murine model (BALB/c), we showed that immunization with either the haemagglutinin (HA) or fusion (F) proteins of MV could protect animals against a fatal challenge (Drillien et al., 1988; Wild et al., 1992) . In similar experiments challenging the mice with another morbillivirus, the closely related canine distemper virus (CDV), mice immunized with VV recombinants expressing the F protein, nucleoprotein (NP) or matrix (M) protein (VV-F, VV-NP and VV-M), were partially protected. In the case of the NP and M proteins, antibody was not involved . Thus, successful vaccination against this type of virus probably involves not only the induction of antibodies, but also CMI.
As the identification of CTL epitopes and their role in CMI could be of crucial importance for measles vaccine development, in the present study we have examined the CTL response induced by MV when expressed from VV vectors. CD8 + CTLs recognize short peptide fragments derived from endogenously synthesized viral proteins 0001-1772 © 1993 SGM presented by class I molecules of the major histocompatibility complex (MHC) at the surface of infected cells (Townsend et al., 1986) . Recognition of a particular peptide is dependent upon the class I MHC haplotype of the host organism. In both humans and mice, the various class I molecules present different CTL epitopes (Townsend & Bodmer, 1989) . We show that in BALB/c mice (H-2 a haplotype) both the HA and NP induce CTLs effective against target cells expressing these antigens. In the in vitro assay, the MV NP-specific CTLs lyse target cells infected by CDV but this was not the case for HAspecific CTLs. In C3H (H-2 k) mice only the NP induced CTLs and as in the case of BALB/c mice, there was a cross-reactivity with CDV. Based on these observations and the recently published methods for predicting motifs for LO-restricted epitopes (Corr et al. 1992) , we tested the ability of a number of peptides derived from the MV NP primary sequence that fulfil the criteria for the L a motif, to sensitize cells for CTL activity. We show that one of these peptides sensitizes P815 cells for CTL activity to the same level as transfected cells expressing the complete NP protein.
Methods
Viruses. The VV recombinants expressing the HA, F, NP and M proteins of MV, VV HA, VV-F, VV NP and VV-M respectively, are as previously described (Drillien et al., 1988; Wild et al., 1992 Wild et al., , 1993 . Viruses were grown in HeLa cells and titrated on Vero cells. The Onderstepoort strain of CDV adapted to suckling mice in the form of mouse brain homogenates was used to establish a persistent infection in P815 cells.
Cells.
The cell lines used as target cells in CTL assays were Ltk (H2k), P815 (H-2 d) and derivatives of these cells expressing high levels of the individual MV antigens HA, F, NP and M as described in Beauverger et al. (1993) . A further Ltk F-expressing cell line was developed which had a higher level of expression than that previously described. Cells were cultivated in DMEM containing 10 % fetal calf serum (FCS). P815 cells transfected with H-2K k (Forquet et al., 1990) were obtained from C. Rabourdin-Combe (Ecole Normale Superieure, Lyon, France).
Mice and immunization. BALB/c (H-2 d) and C3H (H-U) female mice were obtained from IFFA-CREDO, France. Five-to 6-week-old mice were immunized by tail scarification with 107 p.f.u, in 10 gl of inoculum of the VV recombinants. One to 3 months later, the mice were boosted with an intraperitoneal inoculation of 107 p.f.u, and the CTL response was examined 1 month later.
CTL assay. Spleens were removed from immunized animals and, after elimination of red blood cells by perfusion with DMEM, cocultivated with P815 or Ltk cells expressing the corresponding MV protein (HA, F, NP or M) and which had been incubated with mitomycin C (25 gg/ml) for 30 min at 37 °C. The ratio of spleen to stimulator cells was 10:1. The co-cultures (11 × 106 cells/well) were distributed in 24-well plates and incubated at 37 °C in DMEM-10% FCS containing 5 x 10 s M-2-mercaptoethanol. On day 5, half the medium was changed and the cytotoxic activity tested on day 7.
For the CTL assay, the target cells were radiolabelled with 50 gCi SlCr for 90 rain at 37 °C and washed three times in DMEM-1% FCS. The cells were distributed in 96-well plates (5 x I03 cells/100 lal) and the spleen cells from the immunized mice were added in a further 100 ~tl of medium to give an effector to target (E:T) ratio of 100:1, 30:1, 10:1 or 4:1. After 5.5 h incubation at 37 °C, the supernatant of each well was removed and the radioactivity determined by 7-counting. The percentage of cell lysis was calculated as [(experimental c.p.m.)-spontaneous c.p.m.)/(total c.p.m.-spontaneous release)] x 100. Spontaneous release and total release were determined from target cells incubated with medium alone or after the addition of 100 gI of 1 M-HCI, respectively. Peptides. Nonamers of immunopeptide grade based on the sequence of the NP determined for the Hall6 strain ofMV were purchased from Neosystem.
Results

Induction of MV-specific CTLs in BALB/c mice
BALB/c (H-2 ~) mice were immunized with VV recombinants encoding either HA, F, NP or M. The spleen cells were stimulated in vitro by incubating with P815 cells constitutively expressing the corresponding MV protein and the CTL activity was examined 7 days later using the same cells as targets. The mice immunized with either VV-HA or VV-NP induced high levels of CTL activity. Spleen cells from mice immunized with VV-F or VV-M had no detectable CTL activity (Fig. 1) .
To ascertain whether the cross-protection we have reported between MV and CDV may also be observed at the level of CTLs, spleen cells from the VV-recombinantimmunized mice were examined for cytotoxicity on P815 cells infected with CDV (Fig. 1) . In this case, CTL activity was observed only with splenocytes from mice immunized with VV-NP. The activity observed was similar to that in the homologous system suggesting that there was a common epitope.
BALB/c mice express three class I M H C molecules, namely L a, K a and D ~. To examine which of these M H C antigens present the HA and NP peptides, P815-HA and P815-NP cells were used as target cells in the presence of MAbs specific for one of the M H C molecules (Fig. 2) . These studies showed that both the anti-HA and anti-NP CTLs are L~-restricted in BALB/c mice.
Induction of MV-specific CTLs in C3H mice
C3H (H-2 k) mice were immunized with the VV recombinants, their spleen cells were stimulated in vitro with L cells transfected with the corresponding MV gene and the CTL activity was examined 7 days later using the latter as target cells. In these experiments, although VV-F-immunized mice gave a slight CTL signal, the major CTL activity was observed for NP (Fig. 3) . C3H mice express two class I MHC molecules, K k and D k. To determine the M H C restriction, we assayed the NP-specific CTL activity on Ltk -NP cells in the presence of anti-K k or -D k MAb (Fig. 4) . Only the anti-K k antibody reduced the CTL activity.
Unlike the P815 cells, Ltk-cells were not readily infected with the strain of CDV used for our cross- protection experiments. As we had determined that the N P restriction was due to K k in C 3 H mice, we were able to use P815 cells transfected with K k to study any possible C D V cross-reactivity. Spleen cells f r o m V V -N Pvaccinated C 3 H mice were stimulated in vitro with L t k --N P cells and tested for C T L activity on P815 K k cells infected with C D V (Fig. 5) . The CDV-infected cells were very efficiently ( 9 0 % ) lysed by the M V NP-specific spleen cells. In all our assays using L t k -cells, the m a x i m u m lysis was a p p r o x i m a t e l y 5 0 % c o m p a r e d to 90 to 100% in P815 cells. O u r results in Fig. 5 show that the lysis efficiency is inherent to the target cells and n o t a p r o p e r t y o f the C T L s as C 3 H NP-specific spleen cells give a m a x i m u m o f 50 % lysis on L t k -cells and 90 % on P815 K k cells. , 1991) . Recently, C o r r et al. (1992) determined the m o t i f for the L d restriction. T h e y showed it to be a n o n a m e r in which the second a m i n o acid is proline and the ninth can be phenylalanine, leucine or methionine. In the p r i m a r y sequence o f the M V N P there (1985) . (Table 1) . T o study and also verify whether these predictions were valid for the M V NP, the four peptides (nonamers) corresponding to the M V / C D V epitopes and a further two, in which the ninth amino acid was either an alanine or isoleucine residue, were synthesized. The peptides were added to P815 cells at a final concentration of 10 .7 M and tested for lysis with MV NP-specific spleen cells (Fig. 6 ). P815 cells with peptide comprising amino acids 281 to 289 were lysed almost as efficiently as P815-NP cells. The other five peptides caused a degree of lysis close to that of non-transfected P815 control cells.
Identification of the La-restricted N P epitope
Discussion
Considerable progress has been made in characterizing virus-specific CTLs and their role in the control and elimination of virus infections (Lukacher et al., 1984; Kast et al., 1986; Cannon et al., 1987; Reddehase et al., 1987) . In general, virus-specific CTLs have been found to recognize processed viral antigen in association with class I MHC molecules, although class II MHCrestricted CTL responses have recently been documented for a number of viruses (Jacobson et aI., 1985; Morrison et al., 1986; Jin et al., 1988) .
The involvement of CTLs and their phenotype in the recovery from MV infection has been somewhat controversial. Early observations showing the existence of CD8 ÷ HLA class I-restricted T cells after measles infection (Kreth et al., 1979; Lucas et al., 1982; Sethi et al., 1982) were followed by a series of studies on T cells which suggested that CD4 ÷ HLA class II-restricted T cells played the dominant role (Jacobson et al., 1984 (Jacobson et al., , 1989 Richert et al., 1985) . However, later studies showed that, as in most other viral infections, the class I MHCrestricted CTL response by CD8 + T cells may be an important factor in the control and elimination of MV infection (Van Binnendijk et al., 1990) . The role of CTLs in protection against viral diseases is now considered to be an important aspect in the development of new vaccines.
CTLs recognize short peptides bound to the MHC class I heavy chain. These peptides are derived in vivo by cytoplasmic processing. The elution and sequence determination of peptides from different MHC class I molecules has allowed the derivation of allele-specific peptide-binding motifs (R6tzschke et al., 1990; Van Bleek & Nathenson, 1990; Jardetzky et at., 1991) . However, the presence of a motif in a given protein does not automatically imply that this will correspond to a CTL epitope as flanking sequences can affect the manner in which the protein is processed (Del Val et al., 1991; Eisenlohr et al., 1992) . Thus a common strategy is first to identify which viral proteins are targets for anti-viral CTLs, examine the primary sequence of these proteins for the presence of CTL motifs and then synthesize corresponding peptides so that the immunodominant peptide may be identified.
In the present study, we have established that MV proteins expressed from VV induce strong CTL responses, either CDV cross-reactive for the NP antigen in both BALB/c and C3H mice or serotype-specific for the HA protein in the BALB/c haplotype. Our results are in contrast to studies by Niewiesk et al. (1993) who described the HA to be a minor antigen which induces only low levels of CTL activity in BALB/c mice. Furthermore, the NP-specific CTL response in C3H mice was described by these authors to be weak compared with that observed in BALB/c mice. This last point can be explained by our present data which clearly demonstrate that the different lysis efficiencies observed for these two haplotypes are a property of the target cells used and are not due to the NP-specific CTL activity induced in BALB/c and C3H mice. Furthermore the low level of HA CTL activity reported by Niewiesk et al. (1993) may be due to technical differences. In our studies, we have used the cloned genes of the same MV strain (Hall~) throughout for the VV recombinants and the transfected cells were used both as target cells and for in vitro stimulation. In all cases, there is a high level of expression of the MV antigen (Beauverger et al., 1993) . Our MV strain does not replicate in mouse cells, whereas the Edmonston strain used by Niewiesk et al. (1993) does, although the level of expression is not stated. Previous studies by this group have shown that the gradient of viral antigen expression is not the same in all tissues (Schneider-Schaulies et al., 1989) . If the HA was expressed in extremely small quantities, this could account for the low level of lysis they observed for this antigen.
Virus-specific CTLs may be induced by one or more viral proteins. At least seven of the influenza virus proteins have been shown to induce CTL responses in mice (Gould el al., 1991; Cossins et al., 1993) although in general the number of proteins recognized is more restricted, with a single immunodominant epitope present in each. In this study with MV we have shown that in C3H mice only the NP can induce a strong CTL response, whereas in BALB/c mice both the NP and HA do so. Furthermore, we have defined the presentation by the MHC molecules for both antigens in the BALB/c mice to be La-restricted, whereas the NP-specific CTL activity in C3H mice is associated with the K k class I molecule.
The immunological relationship between MV and CDV has been used for the immunization of young dogs against CDV. Our recent studies have shown that partial protection of BALB/c mice against CDV could be obtained after vaccination with VV recombinants expressing the F, NP or M proteins of MV, but not HA. The only cross-reacting antibody induced by the W recombinants was directed against the F protein. No cross-neutralizing antibodies for any of the MV proteins were observed (Wild et al., 1992) . Furthermore, the same protection was observed when the animals were challenged 9 days after vaccination suggesting that a CMI response may be involved. Previous studies by Bankamp et al. (1991) have shown that rats immunized with VV-NP induced class II-specific CTLs. These were shown to protect against an intracerebral challenge by a rat-adapted MV. Although class II CTLs may well be induced, in the present study we decided to elucidate the class I system.
Our present studies have shown that cross-reactivity between the two viruses also exists at the CTL level. In both C3H mice and BALB/c mice this is associated with an epitope in the NP protein. Recently, it has been shown that the predictive motif for the H-2 L a allele is a nonamer in which proline is in the second position and phenylalanine, methionine or leucine is in the ninth (Corr et al., 1992) . In the MV NP sequence there are six such motifs of which four appear in the same position in CDV NP and only two (amino acids 281 to 289 and 329 to 337) have an identical sequence. Peptide 4 which corresponds to amino acids 281 to 289 (Tyr-Pro-Ala-Leu-Gly-LeuHis-Glu-Phe) was found to sensitize P815 cells to CTL lysis to the same level as NP-transfected cells. Rognan et al. (1992) have recently used computer simulation to study the conformations of short antigenic peptides (five to 10 residues) both when free or when bound to H-2 L a. Antigenic potencies were found to correlate with a peptide's propensity to form and maintain an overall ahelical conformation. Peptide 4 is the sole peptide of the six tested which is predicted by a secondary structure computer program to form an overall a-helix. Although these criteria are not valid for certain epitopes, our results agree with these authors' prediction that H-2 L ~ epitopes possess an a-helical conformation. In conclusion, MV proteins induce at least one cross-reactive (NP) CD8 + epitope (amino acids 281 to 289) and one serotype-specific (HA) epitope in BALB/c mice, whereas the NP induces a cross-reactive NP CD8 + epitope in C3H mice.
Although antigenic variation does not appear to be a major problem in MV infections, the observation that CTLs may give a wider protection remains an interesting phenomenon. Infection of humans with different serotypes of dengue virus can lead to grave consequences due to cross-reacting antibodies (Sangdawibha et al., 1984) . It has been suggested that an alternative strategy for this virus would be to vaccinate only for the CTL response, thus avoiding the humoral response. Studies on dengue virus have shown that, depending upon the mouse strain, a limited number of virus antigens may induce CTL activity and that the majority of the epitopes involved induce cross-reactive CTLs (Rothman et al., 1993) .
Viruses are subject to immune pressure, that is, the antigen that induces neutralizing antibodies causes selection for viral variants. Internal antigens are less subject to such selective pressures and are therefore more likely to be conserved. Thus, whenever internal or nonstructural proteins induce CTL activity they should be considered as good candidates to be included in future vaccines.
